Lev Bubis

[Lev Bubis @LevBubis]

@MarkusZiesmann @cutitoutPODCAS1 @StJoesHPB @UnityHealthTO @UofTSurgery @umanitoba @hsc_winnipeg @UM_RadyFHS Thanks @MarkusZiesmann ! Looking forward to making the move and starting up @hsc_winnipeg

@cutitoutPODCAS1 and @m_e_tsang - thanks for a great year @StJoesHPB - phenomenal program!

[Enrique de-Madaria @DeMadaria]

A short history (14 slides) of adjuvant therapy for pancreatic cancer #TheAmylaseSchool #HiloAEG #UEGambassador #GItwitter @EurPancClub @YouppiePancreas @maloehr1 @lelecapurso #PancreaticCancer
👇👇👇

[Mike Pishvaian @MPishvaian]

#GI22

📢Before the meeting gets rolling, I would like to present the abstracts I am keeping my eye👁️on

My Top 10(ish) #PancreaticCancer abstracts
and
My Top 10 non-pancreatic abstracts

[Pablo E Serrano Aybar @SerranoAybar]

PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancreatic stump to preve… https://t.co/Gs5TC9hRx1

[ICES @ICESOntario]

New @ICESOntario study led by @LevBubis & @alyson_mahar looked at patient-reported symptom severity among 22,650 cancer outpatients in the last 6 months of life https://t.co/V7Xy5mVtjn

[Natalie Coburn @DrNCoburn]

Congratulations @niv_vela on his GOLDEN STETHOSCOPE AWARD!! An Outstanding @uoftmedicine #medstudent in the Peters-Boyd Academy @Sunnybrook!!

Great work presented @SocSurgOnc on costs/benefits of adjuvant therapy for #pancreascancer-should be published soon!

[Vaibhav Gupta, MD, PhD @VGupta_MD]

Our study in @AATSJournals looking at esophagectomy readmissions in Ontario:

1. No change in readmission rate over 13 yrs
2. Same at thoracic & non-thoracic centres
3. 18% readmitted at 'best' centre

Not all readmissions are 'bad'

https://t.co/9WtRvVmTr8

#tssmn #SoMe4Surgery

[Julie Hallet @HalletJulie]

Important info on pt-reported symptom burden after #NET diagnosis now in @OncJournal. Frequent symptoms and burden persists over 5y.
Now, need to use this data to ⬆️ early & longitudinal supportive care 🦓 @CNETSCanada

Supported by @NANETS1 @IRSC_CIHR

https://t.co/J16dFAyE4x

[Sergio Acuna, MD, PhD @seacm]

Incorporating Patient Preferences in Non-inferiority Trials: Our proposal to improve the clinical utility and interpretation of non-inferiority trials @JAMA_current @enenbee @tyler_chesney @UofTSurgery

https://t.co/0c4E1s3K6v

[Natalie Coburn @DrNCoburn]

An assessment of 23,840 Stage I-III breast cancer patients shows high rates of symptom burden, especially in younger women, more advanced stage, lower income patients. Can we use this data to improve symptoms during treatment? https://t.co/ac1HJLbNJm

[Marie Ennis-O'Connor @JBBC]

Cancer-related fatigue (CRF) is increasingly recognised as one of the most common and distressing side effects of cancer and its treatments.

It has a negative impact on work, social... https://t.co/mpa3PNE8hD

[Eric Topol @EricTopol]

Individualized post-op management w/ e-health using patient reported outcomes, a RCT @TheLancet https://t.co/fnwrlLcNKH
https://t.co/VR5YJcU9X2

[Natalie Coburn @DrNCoburn]

Can we improve surgical outcomes by promoting exercise, nutrition, and lifestyle modifications prior to major operations? @Sunnybrook team has created a #prehab program for cancer patients @CancerCare_ON

https://t.co/d8JJu8nNIN

[ASCO @ASCO]

Phase III trial: People with surgically removed pancreatic cancer who received mFOLFIRINOX chemo lived a median of 20 months longer than those who received gemcitabine https://t.co/3VGUA2a8DW #ASCO18

[Scott Berry @scottrberry]

PRODIGE 7 : HIPEC added to cytoreductive surgery for isolated CRC peritoneal mets does not improve OS and increases late post-op complications

[NEJM @NEJM]

Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) https://t.co/rQ4b15lb0s #ASCO18

[The Lancet @TheLancet]

Immunoscore for the classification of #coloncancer: study provides a reliable estimate of the risk of recurrence in patients with colon cancer @sitcancer https://t.co/n3SFgZxCED

[Natalie Coburn @DrNCoburn]

Congratulations to Yunni Jeong for her Best Presentation Award at the 2018 Korean Gastric Cancer Association meeting! @UofTSurgery @mygutfeelingca

[Lev Bubis @LevBubis]

Congratulations to @DrNCoburn! So very well-deserved! https://t.co/gqtm1DIvlb

[Lev Bubis @LevBubis]

Laura Davis from @DrNCoburn's team presenting research on province-wide cancer patient-reported outcomes data at CCO Research Day 2018! @ICESOntario @Sunnybrook #PROs #CancerResearch